5/30/2013 10:29:02 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WEST LAFAYETTE, Ind., May 29, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that Mike Sherman, Endocyte's chief financial officer, will present at the upcoming Jefferies 2013 Global Healthcare Conference on Wednesday, June 5, at 4 p.m. EDT. The conference is being held in New York.
Help employers find you! Check out all the jobs and post your resume.
comments powered by